1-deoxynojirimycin has been researched along with Weight Reduction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gianutsos, J; Kolodny, EH; Luzy, C; Pastores, GM; Shapiro, BE | 1 |
| Alfonso, P; Alonso, D; Atutxa, K; Barez, A; Fernández-Galán, MA; Franco, R; Giraldo, P; Latre, P; Martin, A; Pocovi, M | 1 |
| Abel, L; Chadha-Boreham, H; Giorgino, R; Jacklin, E; Luzy, C; Patterson, MC; Vecchio, D; Wraith, JE | 1 |
| Champion, H; Cox, TM; Gallagher, J; Imrie, J; Lachmann, RH; Ramaswami, U; Wraith, JE | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Fehmann, HC | 1 |
| Butters, TD; Dwek, RA; Platt, FM; Priestman, DA; van der Spoel, AC | 1 |
4 trial(s) available for 1-deoxynojirimycin and Weight Reduction
| Article | Year |
|---|---|
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Age of Onset; Diarrhea; Enzyme Inhibitors; Fatigue; Female; Glycoside Hydrolase Inhibitors; Humans; Male; Middle Aged; Tay-Sachs Disease; Time Factors; Treatment Outcome; Weight Loss; Young Adult | 2009 |
Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Chemokines, CC; Child; Enzyme Inhibitors; Female; Gaucher Disease; Glycoside Hydrolase Inhibitors; Hexosaminidases; Humans; Liver; Male; Middle Aged; Organ Size; Prospective Studies; Quality of Life; Spleen; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Loss; Young Adult | 2009 |
Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Child; Deglutition; Diarrhea; Female; Humans; Niemann-Pick Disease, Type C; Walking; Weight Loss | 2010 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
3 other study(ies) available for 1-deoxynojirimycin and Weight Reduction
| Article | Year |
|---|---|
Dietary modifications in patients receiving miglustat.
Topics: 1-Deoxynojirimycin; Adolescent; Adolescent Development; Adult; Age Factors; Child; Child Development; Diet, Carbohydrate-Restricted; England; Enzyme Inhibitors; Gastrointestinal Diseases; Glucosyltransferases; Humans; Lactose; Lysosomal Storage Diseases, Nervous System; Retrospective Studies; Time Factors; Treatment Outcome; Weight Loss; Young Adult | 2010 |
[Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office].
Topics: 1-Deoxynojirimycin; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Family Practice; Feasibility Studies; Female; Follow-Up Studies; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Internal Medicine; Male; Middle Aged; Patient Compliance; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Weight Loss | 2000 |
N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Appetite Regulation; Enzyme Inhibitors; Leptin; Mice; Mice, Obese; Obesity; Weight Loss | 2008 |